Skip to main content

EDITORIAL article

Front. Virol.
Sec. Viral Diversification and Evolution
Volume 4 - 2024 | doi: 10.3389/fviro.2024.1465702
This article is part of the Research Topic Characterization of HIV-1 Variants: Implications for HIV-1 Prevention, Treatment and Cure. View all 5 articles

Editorial: Characterisation of HIV-1 variants: implications for HIV-1 prevention, treatment and cure

Provisionally accepted
Jaclyn Mann Jaclyn Mann 1*Marcel Tongo Marcel Tongo 2Takamasa Ueno Takamasa Ueno 3
  • 1 University of KwaZulu-Natal, Durban, South Africa
  • 2 Center for Research on Emerging Diseases, Institute of Medical Research and Studies of Medicinal Plants (IMPM), Yaoundé, Cameroon
  • 3 Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Kumamoto, Japan

The final, formatted version of the article will be published soon.

    Keywords: HIV-1 diversity, HIV-1 subtypes, transmission, Drug Resistance, latency establishment

    Received: 16 Jul 2024; Accepted: 01 Aug 2024.

    Copyright: © 2024 Mann, Tongo and Ueno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jaclyn Mann, University of KwaZulu-Natal, Durban, South Africa

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.